Literature DB >> 15782670

Is it asthma or COPD? The answer determines proper therapy for chronic airflow obstruction.

Fernando J Martinez1, Connie Standiford, Steven E Gay.   

Abstract

Evaluation and diagnosis of obstructive lung disease call for careful history taking to distinguish asthma from chronic obstructive pulmonary disease (COPD). A history of atopy and intermittent, reactive symptoms points toward a diagnosis of asthma, whereas smoking and advanced age are more indicative of COPD. Clinical features such as cough and wheezing, especially in light of patient history, can be suggestive but are not definitive. Spirometry, usually performed in the primary care setting, is the key diagnostic tool that distinguishes patients with asthma from patients with COPD. In this article, the authors outline an approach to differential diagnosis of asthma and COPD that should result in better evaluation, therapy, and quality of life for these patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15782670     DOI: 10.3810/pgm.2005.03.1593

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  4 in total

1.  The validity of diagnostic support of an asthma/COPD service in primary care.

Authors:  Annelies Lucas; Frank Smeenk; Ivo Smeele; Tim Brouwer; Onno van Schayck
Journal:  Br J Gen Pract       Date:  2007-11       Impact factor: 5.386

2.  The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the Elderly.

Authors:  Amir A Zeki; Michael Schivo; Andrew Chan; Timothy E Albertson; Samuel Louie
Journal:  J Allergy (Cairo)       Date:  2011-10-30

3.  Measurement of the validity and reliability of the persian translation of the saint george respiratory questionnaire for patients with chronic obstructive pulmonary disease.

Authors:  Saeid Fallah Tafti; Ali Cheraghvandi; Mehran Marashian; Habib Emami; Bahareh Mokri
Journal:  Open Respir Med J       Date:  2009-08-04

Review 4.  Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis.

Authors:  A Alshabanat; Z Zafari; O Albanyan; M Dairi; J M FitzGerald
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.